Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation

被引:28
作者
Cetani, F [1 ]
Pardi, E [1 ]
Borsari, S [1 ]
Tonacchera, M [1 ]
Morabito, E [1 ]
Pinchera, A [1 ]
Marcocci, C [1 ]
机构
[1] Univ Pisa, Dipartimento Endocrinol & Metab, I-56125 Pisa, Italy
关键词
D O I
10.1046/j.1365-2265.2003.01696.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES Description of two unrelated Italian kindreds with familial hypocalciuric hypercalcaemia (FHH), an autosomal dominant disease mostly caused by heterozygous inactivating mutations of the Ca2+ sensing receptor (CaR). PATIENTS AND DESIGN We studied 11 members of the two families. Genomic DNA was isolated from peripheral blood leucocytes in all family members and in 50 unrelated Italian controls. Total serum and ionized calcium, PTH, creatinine, phosphate, magnesium, and urinary calcium clearance to creatinine clearance ratio were measured. Direct sequencing of the entire coding region of the CaR was performed in the probands. Functional studies were performed in COS-7 cells transiently expressing the mutated CaR. RESULTS In the proband of family A direct sequencing revealed a novel heterozygous Y218C missense mutation in exon 4. The same mutation was identified in the affected but not in the unaffected family members or in any of the 50 unrelated Italian controls. Transient expression of the Y218C CaR in COS-7 cells revealed a blunted Ca2+ -evoked accumulation of inositol trisphosphates, indicating that the Y218C is a loss-of-function mutation. Cotransfection experiments showed that the mutant receptor had no impact on the function of the wild-type receptor, suggesting that a reduced expression of the normal CaR, rather than a dominant-negative effect, accounted for the functional impairment. In the proband of family B an already described heterozygous P55L missense mutation in exon 2 of the CaR gene was found. The same mutation was identified in the affected family members. CONCLUSIONS We described two familial hypocalciuric hypercalcaemia kindreds with loss-of-function mutations of the Ca2+ receptor gene and identified a novel heterozygous mutation (Y218C) characterized by a blunted response to Ca2+ stimulation compared to the wild-type receptor and no interference with the function of the wild-type Ca2+ receptor.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 31 条
[21]   CALCIUM INFUSION SUGGESTS A SET-POINT ABNORMALITY OF PARATHYROID-GLAND FUNCTION IN FAMILIAL BENIGN HYPERCALCEMIA AND MORE COMPLEX DISTURBANCES IN PRIMARY HYPERPARATHYROIDISM [J].
KHOSLA, S ;
EBELING, PR ;
FIREK, AF ;
BURRITT, MM ;
KAO, PC ;
HEATH, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (03) :715-720
[22]   CAREFULLY MONITORED LEVOTHYROXINE SUPPRESSIVE THERAPY IS NOT ASSOCIATED WITH BONE LOSS IN PREMENOPAUSAL WOMEN [J].
MARCOCCI, C ;
GOLIA, F ;
BRUNOBOSSIO, G ;
VIGNALI, E ;
PINCHERA, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (04) :818-823
[23]   SEQUENCE AND EXPRESSION OF A METABOTROPIC GLUTAMATE RECEPTOR [J].
MASU, M ;
TANABE, Y ;
TSUCHIDA, K ;
SHIGEMOTO, R ;
NAKANISHI, S .
NATURE, 1991, 349 (6312) :760-765
[24]   Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells [J].
Pearce, SHS ;
Bai, M ;
Quinn, SJ ;
Kifor, O ;
Brown, EM ;
Thakker, RV .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (08) :1860-1866
[25]   A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor [J].
Pearce, SHS ;
Williamson, C ;
Kifor, O ;
Bai, M ;
Coulthard, MG ;
Davies, M ;
LewisBarned, N ;
McCredie, D ;
Powell, H ;
KendallTaylor, P ;
Brown, EM ;
Thakker, RV .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1115-1122
[26]   Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism [J].
Pearce, SHS ;
Trump, D ;
Wooding, C ;
Besser, GM ;
Chew, SL ;
Grant, DB ;
Heath, DA ;
Hughes, IA ;
Paterson, CR ;
Whyte, MP ;
Thakker, RV .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (06) :2683-2692
[27]   FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM - EFFECTS OF MUTANT-GENE DOSAGE ON PHENOTYPE [J].
POLLAK, MR ;
CHOU, YHW ;
MARX, SJ ;
STEINMANN, B ;
COLE, DEC ;
BRANDI, ML ;
PAPAPOULOS, SE ;
MENKO, FH ;
HENDY, GN ;
BROWN, EM ;
SEIDMAN, CE ;
SEIDMAN, JG .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) :1108-1112
[28]   AUTOSOMAL-DOMINANT HYPOCALCEMIA CAUSED BY A CA2+-SENSING RECEPTOR GENE MUTATION [J].
POLLAK, MR ;
BROWN, EM ;
ESTEP, HL ;
MCLAINE, PN ;
KIFOR, O ;
PARK, J ;
HEBERT, SC ;
SEIDMAN, CE ;
SEIDMAN, JG .
NATURE GENETICS, 1994, 8 (03) :303-307
[29]   MUTATIONS IN THE HUMAN CA2+-SENSING RECEPTOR GENE CAUSE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA AND NEONATAL SEVERE HYPERPARATHYROIDISM [J].
POLLAK, MR ;
BROWN, EM ;
CHOU, YHW ;
HEBERT, SC ;
MARX, SJ ;
STEINMANN, B ;
LEVI, T ;
SEIDMAN, CE ;
SEIDMAN, JG .
CELL, 1993, 75 (07) :1297-1303
[30]   A new multigene family of putative pheromone receptors [J].
Ryba, NJP ;
Tirindelli, R .
NEURON, 1997, 19 (02) :371-379